From foundational discoveries to profound impact
Without the mRNA technology foundation laid by Karikó and Weissman, the Pfizer/BioNTech and Moderna vaccines being deployed across the world would not exist.
Technology used in mRNA COVID vaccines offers hope for treatment of millions with heart disease, study suggests
Combining technologies that proved hugely success against cancer and in COVID-19 vaccines, researchers at Penn have shown they can effectively treat a leading cause of heart disease.
Vaccine-like mRNA injection can be used to make CAR T cells in the body
The researchers, whose work is published in Science, demonstrated the new approach with an mRNA preparation that reprograms T cells—a powerful type of immune cell—to attack heart fibroblast cells.
Katalin Karikó, PhD, featured on the cover of Newsweek as one of America’s Greatest Disruptors
She was described as being one of the 50 visionaries whose career-long actions have had far-reaching impact.
iECURE partners to develop next-generation liver-targeted lipid nanoparticles with Penn
iECURE announced that it has entered into an exclusive agreement with Penn to develop next-generation lipid nanoparticles (LNP) for liver gene editing applications.
Scout Bio licenses new Penn technology to help develop gene therapies for pets
Scout Bio, a Philadelphia company developing gene therapies for animal health, has licensed a new kind of technology from the Penn’s gene therapy program.
Passage Bio further expands Gene Therapy research partnership with Penn
Passage Bio has exercised two additional options for potential new drug candidates under its research collaboration with Penn's gene therapy program.
A chewing gum that could reduce SARS-CoV-2 transmission
In experiments using saliva samples from COVID-19 patients, the gum, which contains the ACE2 protein, neutralized the virus, according to research led by School of Dental Medicine scientists.
Celebration of Innovation 2021 Recap and Recording
The event honors the patent recipients from the previous fiscal year, as well as, those partners, inventors, and startups that made exceptional achievements.
Developing a chewing gum to reduce the incidence of Covid-19
A chewing gum impregnated with a plant-grown protein can serve as a “trap” for the SARS-CoV-2 virus, reducing viral load in the chewers saliva and potentially tamping down transmission.